Open tenders for Organon France
107 open tenders fit what Organon France offers; 2,394 are in the categories where it won public tenders since 2024.
- Pharmaceutical products · 1 win
- Antineoplastic agents · 1 win
Tenders that fit what Organon France offers
Closest in meaning to its products: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies · Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets. Tenders in other languages match too. Best fit first, top 20 of 107.
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Drospirenon und Ethinylestradiol (ATC-Code: G03AA12).
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
AO MÉDICAMENTS - SYSTÈME GENITO-URINAIRE ET HORMONES SEXUELLES (Classe ATC G) / HORMONES SYSTÉMIQUES, HORMONES SEXUELLES EXCLUES (Classe ATC H)
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu biosimilaren Wirkstoffen
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
36. Generikaausschreibung (2/3er)
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell 2025-02“ der Deutschen Rentenversicherung Knappschaft-Bahn-See
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Open-House-Rabattverträge 2025-05
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu biosimilaren Wirkstoffen ab dem 01.10.2025
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Open-House-Rabattverträge 2025-07
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V für Verträge biosimilarer Wirkstoffe
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Open-House-Rabattverträge 2024-14
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Open-House-Rabattverträge 2025-02
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Open-House-Rabattverträge 2024-02
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nomegestrol + Estradiol, ATC G03AA14 für die Zeit 01.08.25 - 31.07.27 (zzgl. Verlängerungsoption 1x12 Mon.)
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Open-House-Rabattverträge 2025-06
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Open-House-Rabattverträge 2024-07
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
Open-House-Rabattverträge 2025-08
Fits: Prescription medicines for women's health and general conditions, sold to clinicians and patients in more than 140 markets
Arzneimittelverträge mit Beitrittsoption
Fits: Prescription medicines and biosimilars for women's health and general medicine conditions, including contraceptives, fertility treatments and osteoporosis, cardiovascular and respiratory therapies
In the categories Organon France wins
Achiziționarea medicamentelor pentru tratamentul Artritei juvenile în scopul realizării Programului Național „Combaterea maladiilor rare” pentru anul 2027
„Доставка на Darolutamide, заплащан от НЗОК извън цената на клиничните пътеки и процедури, за нуждите на "СБАЛОЗ д-р Марко A. Марков - Варна" ЕООД“
Acord-cadru de furnizare medicamente din Programul Național de Oncologie și Cost Volum, cod PNO4
Amgros 2027 1.370.a
Dostawy leków
Perorální Cytostatikum s obsahovou látkou Belzutifanum
Léčivé přípravky s obsahem ruxolitinibu - Sdružený nákup 2026
Dostawa leków cytostatycznych, w tym leków cytostatycznych niezbędnych do realizacji świadczeń z zakresu chemioterapii i programów lekowych dla potrzeb Beskidzkiego Centrum Onkologii – Szpitala Miejskiego im. Jana Pawła II w Bielsku – Białej
Przetarg nieograniczony - art. 132 Ustawy Prawo zamówień publicznych
Procedura aperta per l’affidamento mediante accordo quadro con più operatori economici della fornitura di farmaci, parafarmaci, SOP, OTC e di tutti i prodotti erogabili nel normale ciclo distributivo delle farmacie
Środki immunosupresyjne
Dostawa produktów leczniczych, wyrobów medycznych oraz środków specjalnego przeznaczenia medycznego
Dostawy produktów leczniczych, żywności specjalnego przeznaczenia medycznego oraz wyrobów medycznych
Nakup farmacevtskih ovojnin
Fourniture de médicaments du système nerveux pour les Etablissements de santé de Bretagne
Dostawa leków
Sukcesywne dostawy produktów leczniczych oraz innych wyrobów medycznych w postaci pasków testowych do samodzielnej kontroli glukozy we krwi, wykorzystywanych przez członków ZRM.
Dostawa produktów do żywienia dojelitowego, pozajelitowego oraz wyrobów medycznych do podaży diet
Dostawa leków i środków dezynfekujących dla Zespołu Opieki Zdrowotnej w Skarżysku-Kamiennej
Dostawa leków stosowanych w programach lekowych
Léčivý přípravek s účinnou látkou OSIMERTINIB-MESILÁT
Léčivý přípravek s účinnou látkou IPILIMUMAB
Dostawa poliheksanidu w ramach Programu lekowego
Zakup wraz z dostawą leków ogólnych, diet dojelitowych i płynów infuzyjnych dla Apteki Szpitalnej Świętokrzyskiego Centrum Onkologii w Kielcach
Zakup i dostawa produktów leczniczych stosowanych w ramach programów lekowych, chemioterapii i poza programami z dostawą do trzech lokalizacji UCK WUM.